Authority: National Company Law Tribunal, Mumbai Court-IV
Order Date: 07.07.2026
Case Overview
The National Company Law Tribunal (NCLT) Mumbai heard a joint company petition (C.P.(CAA)/27/MB/2026) filed under Sections 230 to 232 of the Companies Act, 2013, seeking sanction for a Scheme of Amalgamation. The scheme proposed the amalgamation of Signet Excipients Private Limited (Transferor Company, CIN: U24299MH2019PTC319152) with IMCD India Private Limited (Transferee Company, CIN: U51101MH2014PTC259765). The Transferor Company is engaged in the business of distributing excipients and other chemicals, mainly to the pharmaceutical industry. The Transferee Company distributes specialty chemicals for food, pharmaceutical, beauty, personal care, and industrial segments.
The rationale for the amalgamation was business consolidation. IMCD India had acquired 70% of Signet Excipients in 2020 and the remaining 30% in 2024, making it a 100% subsidiary. The boards believed that post-acquisition alignment was complete and that a full amalgamation was warranted to create a single entity for better management, increased scale, a comprehensive product offering, and operational synergies. The merger is intended to consolidate IMCD's position in the pharmaceutical and nutraceutical segments in India under a unified strategy.
Since IMCD India already holds 100% of the share capital of Signet Excipients, no shares will be issued, and no consideration will be paid as part of this scheme.
The Regional Director (WR), Ministry of Corporate Affairs, filed a report dated 27.04.2026. Key observations and the applicants' responses were:
- The Registrar of Companies, Mumbai, confirmed no pending inquiries, inspections, investigations, or prosecutions against either company and that financial statements were filed up to 31.03.2025.
- Regarding fees paid on authorized capital, the companies undertook to comply with Section 232(3)(i) of the Companies Act, 2013, and pay any differential fees required.
- The companies affirmed that the interests of creditors and employees would be protected.
- The Transferee Company undertook to pass all necessary accounting entries in compliance with applicable Accounting Standards.
- The companies filed an affidavit confirming the scheme filed with the petition was identical to the original application with no discrepancies.
- The companies confirmed serving notices to all concerned regulatory authorities as required.
- The appointed date for the scheme is 01.04.2025, and the companies undertook to comply with the MCA circular dated 21.08.2019 regarding this date.
- The companies undertook to comply with any directions from the Income Tax and GST Departments.
- Regarding a security premium of Rs. 5,64,383 Lakhs collected by IMCD India, the company confirmed filing the requisite Form-2/PAS-3 and complying with the Income Tax Act, 1961.
- The shareholding pattern showed IMCD India held 100% of Signet Excipients, and IMCD Group B.V. (an intermediate holding company) held 94.56% of IMCD India. The ultimate parent is IMCD N.V., a company listed in the Netherlands. The Transferee Company undertook to comply with significant beneficial owner (SBO) disclosure rules under Section 90 of the Companies Act, 2013.
The Official Liquidator filed a report dated 15.04.2026 stating the affairs of the Transferor Company had not been conducted prejudicially to public interest or creditors.
Final Outcome
The NCLT found the scheme fair, reasonable, and not contrary to law or public policy. The petition was allowed, and the Scheme of Amalgamation was sanctioned with an appointed date of 01.04.2025. The scheme is binding on all concerned, including shareholders and creditors. The Transferor Company, Signet Excipients, will be dissolved without winding up. The companies are directed to:
- File a certified copy of the order and scheme with the ROC in e-Form INC-28 within 30 days.
- Submit the order to the Superintendent of Stamps for adjudication of stamp duty within 60 days.
- Comply with all undertakings given to the Tribunal.
- The Income Tax Department retains the liberty to examine the scheme for any potential tax avoidance under the Income-tax Act, 1961.
Topics: Corporate Amalgamation, Regulatory Approval, Business Consolidation